Leronlimab (700mg) Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 2: 1

Top Sponsors

Weill Medical College of Cornell University1

Indications

Mild Cognitive Impairment (MCI) Due to Alzheimer's Disease1
Alzheimer's Disease1

New York, New York1 trial

Safety Assessment of Leronlimab and Its Effect on Brain Inflammation in Alzheimer's Disease

Weill Cornell Medicine Brain Health Imaging Institute

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.